REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/22/2026
Back to search
Official data from USPTO
TRIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
06/23/2026
Trademark type
Word
Nice classes
5, 44
Filing date
03/06/2020
Registration date
06/22/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/22/2021
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/2015
First use in commerce
01/01/2015
Drawing code
4
Owner type
03
Owner location
Monmouth Junction, NJ, US
Examiner
SONNEBORN, TRICIA L
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TRIS PHARMA, INC
Representatives
Cathy A. Kodroff HOWSON & HOWSON, LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsbeta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparationsneuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain
Class 44
Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/22/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2021
PUBO
PUBLISHED FOR OPPOSITION
04/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2021
ALIE
ASSIGNED TO LIE
02/25/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/24/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/03/2020
GNRT
NON-FINAL ACTION E-MAILED
06/03/2020
CNRT
NON-FINAL ACTION WRITTEN
06/03/2020
DOCK
ASSIGNED TO EXAMINER
05/27/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2020
NWAP
NEW APPLICATION ENTERED
03/10/2020
Continuous trademark protection
Get notified about every new filing that threatens TRIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.